Emergent BioSolutions, Inc. (EBS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
"main_header": {
"sid": 1153617,
"name": "Emergent BioSolutions, Inc.",
"stock_name": "Emergent BioSolutions, Inc.",
"full_name": "Emergent BioSolutions, Inc.",
"name_url": "stocks-analysis/emergent-biosolutions-inc",
"exchange": 207,
"exchangecode": "NYS",
"country_id": 2,
"currency": "USD",
"cmp": "12.05",
"chg": 0.45,
"chgp": "3.88%",
"dir": 1,
"prev_price": "11.60",
"mcapval": "412.41",
"mcap": "Micro Cap",
"scripcode": "",
"symbol": "",
"ind_name": "Pharmaceuticals & Biotechnology",
"ind_code": 2305,
"indexname": "S&P 500",
"isin": "US29089Q1058",
"curr_date": "Dec 04",
"curr_time": "",
"bse_nse_vol": "2.25 M",
"exc_status": "Active",
"traded_date": "Dec 04, 2025",
"traded_date_str": "2025 12 04",
"score": "",
"scoreText": "",
"Live": 0,
"market_time": 0,
"is_blur": 1,
"is_blur_class": "blur-register-score-header",
"is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/emergent-biosolutions-inc-1153617-207&utm_source=Spage_Header_Score",
"mojoone": {
"ismore": 0
}
},
"news": {
"results": [
{
"title": "Is Emergent BioSolutions, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-emergent-biosolutions-inc-technically-bullish-or-bearish-3673697",
"imagepath": "",
"date": "2025-11-05 11:22:58",
"description": "As of 31 October 2025, the technical trend for Emergent BioSolutions, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and daily moving averages also indicate a bullish stance. However, the monthly MACD remains mildly bullish, and the KST shows a mixed signal with weekly bullishness and monthly mild bearishness. Bollinger Bands are mildly bullish on both weekly and monthly time frames. The stock has performed well recently, with a 1-week return of 4.13% compared to the S&P 500's 0.71%, but it lags behind the benchmark over longer periods, with a 1-year return of 10.64% versus 19.89% for the S&P 500. Overall, the current technical stance is bullish, supported by strong weekly indicators, despite some mixed signals on the monthly charts...."
},
{
"title": "Is Emergent BioSolutions, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-emergent-biosolutions-inc-technically-bullish-or-bearish-3670871",
"imagepath": "",
"date": "2025-11-04 11:34:27",
"description": "As of 31 October 2025, the technical trend for Emergent BioSolutions, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, indicating positive momentum. The daily moving averages also reflect a bullish stance. However, the KST is mildly bearish on a monthly basis, and the Dow Theory shows a mildly bullish trend for both weekly and monthly periods. Overall, the strength of the bullish signal is supported by the daily moving averages and the weekly MACD. There is no available return data for comparison with the S&P 500...."
},
{
"title": "Is Emergent BioSolutions, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-emergent-biosolutions-inc-technically-bullish-or-bearish-3666476",
"imagepath": "",
"date": "2025-11-03 11:34:12",
"description": "As of 31 October 2025, the technical trend for Emergent BioSolutions, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, supported by bullish signals from the Bollinger Bands and daily moving averages. The monthly MACD is mildly bullish, while the KST shows a mixed signal with a mildly bearish stance. The Dow Theory indicates a mildly bullish trend on both weekly and monthly time frames. \n\nIn terms of performance, the stock has outperformed the S&P 500 significantly over the past week (28.13% vs. 0.71%) and month (35.80% vs. 1.92%), but has underperformed over longer periods, including the past three years and five years. Overall, the current stance is bullish with strong short-term momentum...."
},
{
"title": "Is Emergent BioSolutions, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-emergent-biosolutions-inc-technically-bullish-or-bearish-3664592",
"imagepath": "",
"date": "2025-11-02 11:18:43",
"description": "As of 31 October 2025, the technical trend for Emergent BioSolutions, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands indicate a bullish stance. Daily moving averages also confirm a bullish trend. However, the KST is mildly bearish on a monthly basis, and the Dow Theory shows a mildly bullish signal on both weekly and monthly time frames. \n\nEmergent BioSolutions has outperformed the S&P 500 significantly over the past week and month, with returns of 28.13% and 35.80% compared to the S&P 500's 0.71% and 1.92%, respectively. However, the longer-term performance over three and five years shows substantial underperformance relative to the benchmark. Overall, the current technical stance is bullish, with moderate strength driven by positive indicators in the short term...."
},
{
"title": "Emergent BioSolutions Hits New 52-Week High of $13.41, Up 100.94%",
"link": "https://www.marketsmojo.com/news/stocks-in-action/emergent-biosolutions-hits-new-52-week-high-of-1341-up-10094-3661979",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/EmergentBioSolu_priceRelatedfactors_3661979.png",
"date": "2025-10-31 16:18:51",
"description": "Emergent BioSolutions, Inc. achieved a new 52-week high of USD 13.41 on October 30, 2025, reflecting a year-over-year performance of 100.94%. With a market capitalization of USD 412 million, the company shows a return on equity of 26.51% and a manageable debt-to-equity ratio of 0.74."
},
{
"title": "Is Emergent BioSolutions, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-emergent-biosolutions-inc-technically-bullish-or-bearish-3546596",
"imagepath": "",
"date": "2025-09-20 19:36:34",
"description": "As of 27 August 2025, the technical trend for Emergent BioSolutions, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, supporting the overall positive stance. The daily moving averages are bullish, and both weekly and monthly Bollinger Bands indicate a mildly bullish trend. However, the KST shows a mixed signal with weekly bullishness and monthly mild bearishness, and the OBV is mildly bearish on a weekly basis. \n\nIn terms of performance, the stock has underperformed the S&P 500 across most periods, with a year-to-date return of -16.95% compared to the S&P 500's 12.22%. Despite this, the stock has a positive one-year return of 15.07%, although it lags behind the benchmark's 17.14%. Overall, the current technical stance is mildly bullish, but caution is advised due to mixed signals in some indicators...."
},
{
"title": "Is Emergent BioSolutions, Inc. overvalued or undervalued?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-emergent-biosolutions-inc-overvalued-or-undervalued-3543135",
"imagepath": "",
"date": "2025-09-20 18:11:38",
"description": "As of 6 August 2025, the valuation grade for Emergent BioSolutions, Inc. has moved from risky to attractive, indicating a significant improvement in its investment appeal. The company appears to be undervalued, especially when considering its Price to Book Value of 0.67, EV to Sales ratio of 0.91, and EV to EBITDA of 14.99. In comparison, peers such as Fusion Pharmaceuticals, Inc. exhibit a risky valuation with an EV to EBITDA of -15.5851, while Rigel Pharmaceuticals, Inc. is rated very attractive with an EV to EBITDA of 6.4016.\n\nDespite the lack of return data for the company, its recent valuation change suggests a positive outlook compared to the broader market. The current price of $7.94, alongside a notable 52-week high of $12.73, reinforces the notion that the stock may be positioned for recovery and growth...."
}
],
"total": 12,
"sid": "1153617",
"stock_news_url": "https://www.marketsmojo.com/news/emergent-biosolutions-inc-1153617"
},
"announcements": "",
"corporate_actions": {
"msg": "No corporate action Found"
}
}

News and Views

Is Emergent BioSolutions, Inc. technically bullish or bearish?

2025-11-05 11:22:58

As of 31 October 2025, the technical trend for Emergent BioSolutions, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and daily moving averages also indicate a bullish stance. However, the monthly MACD remains mildly bullish, and the KST shows a mixed signal with weekly bullishness and monthly mild bearishness. Bollinger Bands are mildly bullish on both weekly and monthly time frames. The stock has performed well recently, with a 1-week return of 4.13% compared to the S&P 500's 0.71%, but it lags behind the benchmark over longer periods, with a 1-year return of 10.64% versus 19.89% for the S&P 500. Overall, the current technical stance is bullish, supported by strong weekly indicators, despite some mixed signals on the monthly charts....

Is Emergent BioSolutions, Inc. technically bullish or bearish?

2025-11-04 11:34:27

As of 31 October 2025, the technical trend for Emergent BioSolutions, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, indicating positive momentum. The daily moving averages also reflect a bullish stance. However, the KST is mildly bearish on a monthly basis, and the Dow Theory shows a mildly bullish trend for both weekly and monthly periods. Overall, the strength of the bullish signal is supported by the daily moving averages and the weekly MACD. There is no available return data for comparison with the S&P 500....

Is Emergent BioSolutions, Inc. technically bullish or bearish?

2025-11-03 11:34:12

As of 31 October 2025, the technical trend for Emergent BioSolutions, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, supported by bullish signals from the Bollinger Bands and daily moving averages. The monthly MACD is mildly bullish, while the KST shows a mixed signal with a mildly bearish stance. The Dow Theory indicates a mildly bullish trend on both weekly and monthly time frames. In terms of performance, the stock has outperformed the S&P 500 significantly over the past week (28.13% vs. 0.71%) and month (35.80% vs. 1.92%), but has underperformed over longer periods, including the past three years and five years. Overall, the current stance is bullish with strong short-term momentum....

Is Emergent BioSolutions, Inc. technically bullish or bearish?

2025-11-02 11:18:43

As of 31 October 2025, the technical trend for Emergent BioSolutions, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands indicate a bullish stance. Daily moving averages also confirm a bullish trend. However, the KST is mildly bearish on a monthly basis, and the Dow Theory shows a mildly bullish signal on both weekly and monthly time frames. Emergent BioSolutions has outperformed the S&P 500 significantly over the past week and month, with returns of 28.13% and 35.80% compared to the S&P 500's 0.71% and 1.92%, respectively. However, the longer-term performance over three and five years shows substantial underperformance relative to the benchmark. Overall, the current technical stance is bullish, with moderate strength driven by positive indicators in the short term....

Emergent BioSolutions Hits New 52-Week High of $13.41, Up 100.94%

2025-10-31 16:18:51

Emergent BioSolutions, Inc. achieved a new 52-week high of USD 13.41 on October 30, 2025, reflecting a year-over-year performance of 100.94%. With a market capitalization of USD 412 million, the company shows a return on equity of 26.51% and a manageable debt-to-equity ratio of 0.74.

Is Emergent BioSolutions, Inc. technically bullish or bearish?

2025-09-20 19:36:34

As of 27 August 2025, the technical trend for Emergent BioSolutions, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, supporting the overall positive stance. The daily moving averages are bullish, and both weekly and monthly Bollinger Bands indicate a mildly bullish trend. However, the KST shows a mixed signal with weekly bullishness and monthly mild bearishness, and the OBV is mildly bearish on a weekly basis. In terms of performance, the stock has underperformed the S&P 500 across most periods, with a year-to-date return of -16.95% compared to the S&P 500's 12.22%. Despite this, the stock has a positive one-year return of 15.07%, although it lags behind the benchmark's 17.14%. Overall, the current technical stance is mildly bullish, but caution is advised due to mixed signals in some indicators....

Is Emergent BioSolutions, Inc. overvalued or undervalued?

2025-09-20 18:11:38

As of 6 August 2025, the valuation grade for Emergent BioSolutions, Inc. has moved from risky to attractive, indicating a significant improvement in its investment appeal. The company appears to be undervalued, especially when considering its Price to Book Value of 0.67, EV to Sales ratio of 0.91, and EV to EBITDA of 14.99. In comparison, peers such as Fusion Pharmaceuticals, Inc. exhibit a risky valuation with an EV to EBITDA of -15.5851, while Rigel Pharmaceuticals, Inc. is rated very attractive with an EV to EBITDA of 6.4016. Despite the lack of return data for the company, its recent valuation change suggests a positive outlook compared to the broader market. The current price of $7.94, alongside a notable 52-week high of $12.73, reinforces the notion that the stock may be positioned for recovery and growth....

View All News